questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Mitogen-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases
JNK Mitogen-Activated Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Kinases
Signalisation cellulaire
Biomarqueurs
Phosphorylation
Tests génétiques
Mutations
Imagerie par résonance magnétique
Effets cellulaires
Échantillons sanguins
Marqueurs d'activation
Symptômes
5
Cancer
Maladies neurodégénératives
Troubles cognitifs
Troubles de l'humeur
Prévention
5
Mode de vie sain
Alimentation équilibrée
Stress oxydatif
Gestion du stress
Antioxydants
Stress oxydatif
Exercice physique
Modulation
Habitudes alimentaires
Nutriments
Traitements
5
Inhibiteurs
Développement thérapeutique
Anti-inflammatoires
Modulation
Thérapie génique
Dysfonctionnements
Plantes médicinales
Activation
Traitements anticancéreux
Cellules tumorales
Complications
5
Maladies inflammatoires
Cancer
Complications cardiovasculaires
Maladies cardiovasculaires
Vieillissement cellulaire
Activation prolongée
Troubles neurodégénératifs
Activation
Troubles métaboliques
Diabète
Facteurs de risque
5
Stress
Inflammation chronique
Alimentation
Graisses saturées
Tabagisme
Facteurs de risque
Toxines environnementales
Activation
Mode de vie sédentaire
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "JNK Mitogen-Activated Protein Kinases : Questions médicales les plus fréquentes",
"headline": "JNK Mitogen-Activated Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les JNK Mitogen-Activated Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "JNK Mitogen-Activated Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D020928",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D020928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 8",
"alternateName": "Mitogen-Activated Protein Kinase 8",
"url": "https://questionsmedicales.fr/mesh/D048055",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 8",
"code": {
"@type": "MedicalCode",
"code": "D048055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 9",
"alternateName": "Mitogen-Activated Protein Kinase 9",
"url": "https://questionsmedicales.fr/mesh/D048056",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 9",
"code": {
"@type": "MedicalCode",
"code": "D048056",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase 10",
"alternateName": "Mitogen-Activated Protein Kinase 10",
"url": "https://questionsmedicales.fr/mesh/D048057",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase 10",
"code": {
"@type": "MedicalCode",
"code": "D048057",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.567.374.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "JNK Mitogen-Activated Protein Kinases",
"alternateName": "JNK Mitogen-Activated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D048031",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mohammad Shafiq",
"url": "https://questionsmedicales.fr/author/Mohammad%20Shafiq",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Kumaravelu Jagavelu",
"url": "https://questionsmedicales.fr/author/Kumaravelu%20Jagavelu",
"affiliation": {
"@type": "Organization",
"name": "From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Neeraj Kumar Verma",
"url": "https://questionsmedicales.fr/author/Neeraj%20Kumar%20Verma",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Jimut Kanti Ghosh",
"url": "https://questionsmedicales.fr/author/Jimut%20Kanti%20Ghosh",
"affiliation": {
"@type": "Organization",
"name": "Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India."
}
},
{
"@type": "Person",
"name": "Matthias Gaestel",
"url": "https://questionsmedicales.fr/author/Matthias%20Gaestel",
"affiliation": {
"@type": "Organization",
"name": "Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Diagnostic imaging of retinal astrocytomas: A case-series.",
"datePublished": "2022-10-12",
"url": "https://questionsmedicales.fr/article/36224356",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-022-02275-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vasoproliferative retinal tumors: Clinical presentation and treatment outcome.",
"datePublished": "2022-12-27",
"url": "https://questionsmedicales.fr/article/36575603",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/11206721221149075"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical and Genetic Characteristics of Retinal Capillary Hemangioblastoma in Korean Patients.",
"datePublished": "2022-10-25",
"url": "https://questionsmedicales.fr/article/36281577",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3341/kjo.2022.0079"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retinal cavernous hemangioma in a newborn: an unusual presentation of a rare tumor.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36126880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaapos.2022.08.260"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vitrectomy-Assisted Excision in the Treatment of Juxtapapillary Retinal Capillary Hemangioma.",
"datePublished": "2022-10-01",
"url": "https://questionsmedicales.fr/article/36239674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/23258160-20220907-01"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mitogen-Activated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D020928"
},
{
"@type": "ListItem",
"position": 7,
"name": "JNK Mitogen-Activated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D048031"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : JNK Mitogen-Activated Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur JNK Mitogen-Activated Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur JNK Mitogen-Activated Protein Kinases",
"description": "Comment diagnostiquer une activation des JNK ?\nQuels biomarqueurs indiquent l'activation des JNK ?\nLes tests génétiques sont-ils utiles pour les JNK ?\nQuels examens d'imagerie sont utilisés pour les JNK ?\nPeut-on mesurer l'activité des JNK dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Retinal+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels symptômes sont liés à l'activation des JNK ?\nLes JNK sont-ils impliqués dans des maladies ?\nComment les JNK affectent-ils la douleur ?\nLes JNK influencent-ils le métabolisme ?\nY a-t-il des symptômes neurologiques associés aux JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Retinal+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur JNK Mitogen-Activated Protein Kinases",
"description": "Comment prévenir l'activation des JNK ?\nLe stress influence-t-il les JNK ?\nLes antioxydants aident-ils à prévenir l'activation des JNK ?\nL'exercice physique prévient-il l'activation des JNK ?\nLes habitudes alimentaires influencent-elles les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Retinal+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels traitements ciblent les JNK ?\nLes anti-inflammatoires affectent-ils les JNK ?\nLa thérapie génique peut-elle cibler les JNK ?\nLes traitements naturels influencent-ils les JNK ?\nLes traitements anticancéreux ciblent-ils les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Retinal+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur JNK Mitogen-Activated Protein Kinases",
"description": "Quelles complications sont liées à l'activation des JNK ?\nLes JNK sont-ils liés à des complications cardiovasculaires ?\nLes JNK influencent-ils le vieillissement cellulaire ?\nY a-t-il des complications neurologiques liées aux JNK ?\nLes JNK sont-ils impliqués dans des complications métaboliques ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Retinal+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur JNK Mitogen-Activated Protein Kinases",
"description": "Quels facteurs de risque influencent les JNK ?\nL'alimentation affecte-t-elle les JNK ?\nLe tabagisme influence-t-il les JNK ?\nL'exposition à des toxines affecte-t-elle les JNK ?\nLe manque d'exercice est-il un facteur de risque pour les JNK ?",
"url": "https://questionsmedicales.fr/mesh/D048031?mesh_terms=Retinal+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une activation des JNK ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de signalisation cellulaire et des analyses protéomiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs indiquent l'activation des JNK ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de protéines phosphorylées c-Jun peuvent indiquer une activation."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les JNK ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests peuvent identifier des mutations affectant la voie JNK."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont utilisés pour les JNK ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique peut aider à visualiser des effets cellulaires."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer l'activité des JNK dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons sanguins peuvent être analysés pour des marqueurs d'activation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'activation des JNK ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activation peut entraîner inflammation, apoptose et dysfonction cellulaire."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils impliqués dans des maladies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont associés à des maladies comme le cancer et les maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Comment les JNK affectent-ils la douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils modulent la signalisation de la douleur, contribuant à des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les JNK influencent-ils le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils jouent un rôle dans la régulation du métabolisme énergétique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés aux JNK ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et des troubles de l'humeur peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation des JNK ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les JNK ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut activer les JNK, donc la gestion du stress est cruciale."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à prévenir l'activation des JNK ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire le stress oxydatif et l'activation des JNK."
}
},
{
"@type": "Question",
"name": "L'exercice physique prévient-il l'activation des JNK ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut moduler positivement l'activité des JNK."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les JNK ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en nutriments peut réduire l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les JNK ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des JNK sont en développement pour diverses maladies."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires affectent-ils les JNK ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains anti-inflammatoires peuvent moduler l'activité des JNK."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle cibler les JNK ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger des dysfonctionnements des JNK."
}
},
{
"@type": "Question",
"name": "Les traitements naturels influencent-ils les JNK ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir un effet sur l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Les traitements anticancéreux ciblent-ils les JNK ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements anticancéreux visent à inhiber les voies JNK dans les cellules tumorales."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à l'activation des JNK ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activation excessive des JNK peut entraîner des maladies inflammatoires et cancéreuses."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils liés à des complications cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des JNK est associée à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les JNK influencent-ils le vieillissement cellulaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation prolongée des JNK peut accélérer le vieillissement cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques liées aux JNK ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activation des JNK est impliquée dans des troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Les JNK sont-ils impliqués dans des complications métaboliques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont liés à des troubles métaboliques comme le diabète."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les JNK ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, l'inflammation chronique et l'obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle les JNK ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter l'activation des JNK."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les JNK ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque qui peut activer les JNK."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle les JNK ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut activer les JNK."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque pour les JNK ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque d'activation des JNK."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 05/05/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Division of Molecular and Structural Biology (N.K.V., J.K.G.), CSIR-Central Drug Research Institute, Lucknow, India.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Institute for Zellbiochemie, Medizinische Hochschule Hannover (MHH), Hanover, Germany (M.G.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
From the Division of Pharmacology (M.S., K.J., K.H.), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research, Ghaziabad, India (M.S., K.J., K.H.).
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
College of Life Sciences and National Key Laboratory of Crop Genetics and Germplasm Enhancement, Nanjing Agricultural University, Nanjing 210095, China.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratório Especial de Dor e Sinalização, Instituto Butantan, São Paulo, Brazil.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
Department of Life Science (BK21 program), Chung-Ang University, Seoul, South Korea.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. tayebmuhammad@nwsuaf.edu.cn.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. tayebmuhammad@nwsuaf.edu.cn.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. 15591858981@163.com.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. 15591858981@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. 15891785931@163.com.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. 15891785931@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. liyushunaf@163.com.
State Key Laboratory of Crop Stress Biology in Arid Regions, Northwest A&F University, Yangling 712100, China. liyushunaf@163.com.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
1 publication dans cette catégorie
Affiliations :
College of Horticulture, Northwest A&F University, Yangling 712100, China. feizhang@nwsuaf.edu.cn.
Publications dans "JNK Mitogen-Activated Protein Kinases" :
To use multimodal imaging techniques to characterise features of retinal astrocytomas (RA) which would aid practitioners distinguish them from other causes of non-pigmented fundal lesions....
Retrospective analysis of notes and imaging of 17 patients diagnosed with RA at a single centre between January 2012 and June 2021 was conducted. Demographics, examination findings and imaging includi...
Fourteen patients (82%; 14/17) had idiopathic RA and three (18%; 3/17) were associated with tuberous sclerosis. Mean age at presentation was 43 years. Twelve patients (71%; 12/17) were asymptomatic. T...
RAs display characteristic clinical, demographic and imaging features which can aid differentiating them from other non-pigmented fundal lesions. We advise using multiple imaging modalities when diagn...
To study the clinical presentation and treatment outcomes of patients with vasoproliferative retinal tumor (VPRT) in India....
Retrospective study of 50 eyes in 47 patients....
Of the 50 eyes, 25 (50%) were primary and 25 (50%) were secondary. Common ocular pathologies related to secondary VPRT included retinal detachment (n = 8, 32%) and Coats disease (n = 7, 28%). Overall,...
VPRTs commonly present as a unilateral lesions in the adult population with equal prevalence of primary and secondary variants. Compared with primary VPRT, secondary VPRTs require surgical treatment a...
We investigated the clinical features of Korean patients with retinal capillary hemangioblastoma (RCH) and genetic variants of the von Hippel-Lindau (VHL) gene....
A retrospective analysis was performed on patients with RCH from 2003 to 2021 at Seoul National University Bundang Hospital. Sporadic and hereditary RCH associated with VHL disease were classified bas...
A total of 18 patients (23 eyes) were enrolled in this study. The mean age at diagnosis was 37 ± 15 years. Twelve patients had hereditary RCH associated with VHL disease, and six patients had sporadic...
In Korean patients with RCH, bilateral involvement and juxtapapillary RCH are highly likely to be associated with VHL disease. Because RCH may be the first clinical manifestation in patients with VHL,...
Retinal cavernous hemangioma (RCavH) is an uncommon, benign, vascular tumor of venous aneurysms. It can be sporadic or inherited in an autosomal-dominant pattern as part of an oculoneurocutaneous synd...
Juxtapapillary retinal capillary hemangiomas are sight-threatening hamartomas located on or adjacent to the optic nerve. Nonsurgical approaches including laser photocoagulation and cryotherapy have be...
To identify retinal changes using spectral-domain optical coherence tomography (SD-OCT) and ultra-widefield images in eyes with primary vitreoretinal lymphoma (PVRL) during intravitreal methotrexate (...
At the initial visit, the OCT manifestations included vitreous cells (105 eyes, 94.6%), intraretinal infiltration (44 eyes,39.6%), subretinal infiltration (45 eyes, 40.5%,), retinal pigment epithelium...
SD-OCT combined with ultra-widefield imaging, which can reflect retinal changes, are valuable tools for monitoring the effect of PVRL treatment....
An early adolescent man was referred to the ocular oncology service for evaluation of a pale, raised fundus lesion in the inferotemporal quadrant of his right eye. Unaided visual acuities were 20/20 O...
Intraocular tumors constitute a small subset of cases in ophthalmologic practice. Proper diagnosis of intraocular tumors is crucial because some pose threat to vision and life, while others may indica...
We report the case of a 60-year-old woman who presented with metamorphopsia and progressive vision loss in the right eye. Fundus examination revealed an elevated, white-yellow mass in the peripheral i...
A man in his 20s presented with diminished vision in the left eye. He had a history of Pott's spine and had been diagnosed elsewhere as having left eye tubercular granuloma in the retina. He was start...